Physician profile
Sajida Mathew
NPI 1164510509
$3,505.58
in general payments reported to CMS, 2019-2025
17 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $842 · 2021: $1,605 · 2022: $185 · 2023: $153 · 2024: $122 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $500.93 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $416.34 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $415.68 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $323.23 | 2020-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $317.71 | 2019-2021 | |
| Alkermes, INC. | $299.91 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $252.49 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $248.06 | 2019-2021 | |
| Allergan, INC. | $131.74 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $122.12 | 2024 | Cobenfy |
| Sunovion Pharmaceuticals INC. | $121.05 | 2019-2021 | |
| Lundbeck LLC | $94.51 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.06 | 2019-2021 | |
| Indivior INC. | $73.47 | 2019-2021 | |
| Axsome Therapeutics, INC. | $72.78 | 2023 | Auvelity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $19.61 | 2021 | |
| Noven Therapeutics, LLC | $14.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sajida Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.